Supraventricular tachycardia AHA recommendations for Management of IST: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{AA}} | {{CMG}} {{AE}}{{AA}} | ||
==Overview== | ==Overview== | ||
== | ==Acute treatment of IST ([[Inappropriate sinus tachycardia]])== | ||
There are no specific recommendations for acute treatment of IST. | |||
==Treatment of ongoing IST (Inappropriate sinus tachycardia)== | |||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
|- | |- |
Revision as of 14:15, 26 October 2016
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of IST On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of IST |
FDA on Supraventricular tachycardia AHA recommendations for Management of IST |
CDC on Supraventricular tachycardia AHA recommendations for Management of IST |
Supraventricular tachycardia AHA recommendations for Management of IST in the news |
Blogs on Supraventricular tachycardia AHA recommendations for Management of IST |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Acute treatment of IST (Inappropriate sinus tachycardia)
There are no specific recommendations for acute treatment of IST.
Treatment of ongoing IST (Inappropriate sinus tachycardia)
Class I |
"1.Evaluation for and treatment of reversible causes are recommended in patients with suspected IST "(Level of Evidence: C-LD) " |
Class IIa |
"1.Ivabradine is reasonable for ongoing management in patients with symptomatic IST "(Level of Evidence: B-R) " |
Class IIb |
"1.Beta blockers may be considered for ongoing management in patients with symptomatic IST "(Level of Evidence:C-LD) " |
"2.The combination of beta blockers and ivabradine may be considered for ongoing management in patients with IST ( "(Level of Evidence: C-LD) " |